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Can supplementary dietary fibre suppress breast cancer growth?
BA Stoll
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Summary Case-control studies in diverse populations around the world have reported a lower risk of breast
cancer in association with higher intake ofdietary fibre and complex carbohydrates. Although this has not been
confirmed in prospective studies in the USA, the observations have prompted the hypothesis that prolonged
use of dietary fibre supplements might reduce breast cancer risk in high-incidence populations. Several possible
mechanisms of action have been suggested, all involving a reduction of bioactive oestrogen levels in the blood.
The various mechanisms are not necessarily mutually exclusive. First, a high-fibre diet might reduce circulating
oestrogen levels by reducing the enterohepatic recirculation of oestrogen. Second, many plants and vegetables
contain isoflavones and lignans capable of conversion in the bowel into weak oestrogens that may compete
with oestradiol for target binding-sites. Third, a high-fibre diet is less often associated with obesity, which tends
to increase availability of the biologically active 16-alpha metabolites of oestrone. Fourth, a high-fibre diet
usually has a lower content of fat and a higher content of antioxidant vitamins, which may protect against
breast cancer risk. Finally, diets rich in fibre and complex carbohydrates have been shown to improve insulin
sensitivity, with an associated reduction in circulating oestrogen levels. Synergism between these effects offers a
possible mechanism by which a high fibre intake might suppress breast cancer growth in women.
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Mortality rates for breast cancer vary widely throughout the
world and are about five times as high in women in Northern
Europe and North America as in Oriental women.
International correlations between dietary fat content and
breast cancer mortality rates have led to the hypothesis that a
fat-rich diet may favour the development of breast cancer.
However, most case-control and cohort studies have failed
to show anything more than a very weak positive correlation
between dietary fat content and breast cancer risk. This does
not exclude the possibility that reducing fat intake at an
earlier period in life, or well below 30% of total energy
intake, might influence breast cancer rates (Willett, 1989).
Indeed, the National Institutes of Health in the USA have
initiated a trial to assess the effect on women's breast cancer
risk of a diet with only 20% of calories derived from fat
(Greenwald, 1993).
Attempts have been made to explain the international
correlation between high levels of dietary fat and breast
cancer risk by relating it to blood levels of oestrogen
fractions in different populations. Oestrogen levels are
generally lower in Oriental women than in Western women
but in the post-menopausal age group this is mainly related
to differences in body mass (Bernstein and Ross, 1993). Pre-
and post-menopausal breast cancer may involve different risk
factors, and the much greater international variation in the
incidence of the post-menopausal disease has led some to
emphasise a role for nutritional factors predominantly in
older women (Graham et al., 1991; Kushi et al., 1992). Only
in post-menopausal women is obesity a risk marker for breast
cancer, and some studies suggest that obesity may be
asociated with increased 16-alpha hydroxylation of oestra-
diol (Schneider et al., 1983).
Dietary fibre and breast cancer risk
For many years nutritional studies of the development and
growth of human mammary cancer have focused on
assessment of increased consumption of fat and protein.
However, a protective role for dietary fibre (non-starch
polysaccharide) has been increasingly postulated, since case-
control studies from many countries have shown a decreased
risk of breast cancer in relation to high intake of dietary fibre
and complex carbohydrates (Kolonel et al., 1981; Lubin et
al., 1986; Brisson et al., 1989; Pryor et al., 1989; Iscovich et
al., 1989; Van't Veer et al., 1990; Lee et al., 1991; Graham et
al., 1991; Zaridze et al., 1991; Levi et al., 1993; Rohan et al.,
1993; Baghurst and Rohan; 1994; Trichopoulou et al., 1995;
Yuan et al., 1995). While a meta-analysis concluded that a
protective effect was likely (Block et al., 1992), the absence of
such an association in two large prospective studies in the
USA is notable (Kushi et al., 1992; Willett et al., 1992). The
inconsistency may relate either to differences in the specific
types of dietary fibre consumed by different populations
around the world, or else to relative lack of variability in
fibre intake within the USA.
Although some studies show a greater effect from high
dietary fibre on the risk of post-menopausal breast cancer
(Lubin et al., 1986; Lee et al., 1991), others show a similar
effect in both younger and older women. Studies of
vegetarians have shown lower blood levels of oestradiol in
both pre- and post-menopausal women (Goldin et al., 1982;
Barbosa et al., 1990). The mechanism is uncertain, but
oestrogen metabolites are excreted in the bile, and intestinal
flora and enzymes convert them to oestradiol, which is then
partially reabsorbed. Some types of dietary fibre can diminish
reabsorption in premenopausal women, thereby reducing the
circulating oestrogen level (Schultz and Howie, 1986; Rose,
1990; Adlercreutz, 1990). It is reported that food supplements
of wheat bran (but not of oat or corn bran) cause a
significant fall in oestrogen levels in premenopasal women
without any change in dietary fat consumption (Rose et al.,
1991).
Some types of dietary fibre may protect against breast
cancer through their conversion by intestinal flora to agents
with both oestrogenic and antioestrogenic effects on target
tissue. Isoflavones are found particularly in soy products and
these are consumed widely by Oriental women, who also have
a low incidence of breast cancer. It has been shown that some
chemically induced mammary cancers in rats can be inhibited
either by soy feeding (Messina et al., 1994) or by
supplementary dietary fibre (Cohen et al., 1991). Several
investigators are currently investigating the effects of soy
protein supplements on sex hormone levels in pre- and post-
menopausal Caucasian women.
Indole-3-carbinol is a naturally occurring agent (found in
vegetables such as cabbage, broccoli, Brussels sprouts and
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cauliflower) which is claimed to have anti-cancer properties
(Beecher, 1994). A derivative of this agent is reported to exert
both oestrogenic and antioestrogenic effects on human
mammary cancer cells in culture (Liu et al., 1994). Thus,
the protective effect of vegetables and plants may be due to
factors independent of their content of fibre or antioxidant
vitamins, but we still need to identify those containing agents
of which the antioestrogenic effect is clearly greater than their
oestrogenic effect (Goldin, 1994).
An alternative mechanism may be through a high-fibre
diet antagonising the development of insulin resistance. While
a fat-rich diet may stimulate the development of insulin
resistance, diets rich in fibre and complex carbohydrates have
the opposite effect (Smith, 1994). A case-control study in the
Netherlands has shown insulin resistance and hyperinsulinae-
mia to be a risk marker for breast cancer (Bruning et al.,
1992). Stimulation of breast cancer growth may involve
synergism between oestradiol and insulin-like growth factor 1
in a mitogenic effect on breast tissue (Stewart et al., 1990). A
tendency to insulin resistance is genetically determined but
can be triggered by a fat-rich diet (Zimmet, 1993). Insulin
resistance is commonly associated with an elevated level of
bioavailable oestrogen (Bruning et al., 1992), and this
observation has prompted the hypothesis that breast cancer
may be promoted at critical times in a woman's life by the
metabolic/endocrine abnormality (Stoll, 1995).
It is claimed that raised blood insulin levels can be reduced
by a diet rich in fibre and complex carbohydrate (Anderson,
1977). In a group of 29 subjects with hyperinsulinaemia, 17
achieved normalisation of insulin levels after 3 weeks on a
high-carbohydrate, high-fibre diet combined with daily
exercise (Barnard et al., 1992). Long-term high dietary fibre
intake is more likely to improve insulin sensitivity (Lovejoy
and Di Girolamo, 1992) and such an effect can be achieved in
all age groups (Fukagawa et al., 1990). It has been suggested
that the beneficial effect of a high carbohydrate, low-fat diet
is more closely related to its fibre content than to its
carbohydrate content (Riccardi et al., 1984).
Conclusion
It is possible to test the hypothesis that breast cancer growth
may be suppressed by synergism between improved insulin
sensitivity and a reduced level of bioavailable oestrogen.
High-fibre supplements could be given in a trial of adjuvant
dietary treatment following primary surgery in both pre- and
post-menopausal women with early breast cancer. Any
possible effect on prognosis could be correlated with
observations on insulin and oestrogen levels in the serum.
Such a trial would expand the observations of an adjuvant
dietary fat-reduction trial in post menopausal women
(Chlebowski et al., 1991) at present under way in the USA
with the participation of 20 centres (DP Rose, personal
communication).
Meanwhile, the available evidence of benefit from high
dietary fibre suggests that breast cancer patients who wish to
adopt a healthier diet might include such a measure, even if
the optimal fibre constituents are still uncertain. Future
research should aim to identify specific types of fat and
dietary fibre for testing in intervention trials.
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